Literature DB >> 4699650

Sebaceous gland secretion in Parkinson's disease during L-dopa treatment.

S R Kohn, P E Pochi, J S Strauss, D S Sax, R G Feldman, W H Timberlake.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4699650     DOI: 10.1111/1523-1747.ep12682040

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

1.  Skin function and skin disorders in Parkinson's disease.

Authors:  M Fischer; I Gemende; W C Marsch; P A Fischer
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

Review 2.  Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.

Authors:  Eva Schaeffer; Daniela Berg
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

3.  Malassezia and Parkinson's Disease.

Authors:  Martin Laurence; Julián Benito-León; Frédéric Calon
Journal:  Front Neurol       Date:  2019-07-24       Impact factor: 4.003

Review 4.  The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials.

Authors:  Odeh Alsmeirat; Som Lakhani; Musab Egaimi; Osama Idris; Mohamed Elkhalifa
Journal:  Cureus       Date:  2022-08-02

Review 5.  The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.

Authors:  Matej Skorvanek; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2016-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.